Sales and Marketing

Showing 15 posts of 11527 posts found.

Zaltrap launched in UK

March 4, 2013 Sales and Marketing Sanofi, Zaltrap

Sanofi and Regeneron Pharmaceuticals’ bowel cancer drug Zaltrap has been launched in the UK today. Zaltrap (aflibercept) will be used …

Boehringer targets AML

March 1, 2013 Research and Development, Sales and Marketing AML, Boehringer

Boehringer Ingelheim is to begin a pivotal trial of its investigative treatment volasertib in patients with acute myeloid leukaemia (AML). …

Lundbeck booze pill for EU

March 1, 2013 Sales and Marketing Lundbeck, alcohol, selincro

Lundbeck’s novel pill Selincro has been given European marketing authorisation to help patients with a drink problem to cut down. …

RSA welcomes pan-European consultant

February 28, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing rsa

Life sciences executive search and interim management firm RSA has announced that Dr Theo de Roij has joined the pan-European …

Eliquis approved by NICE

February 28, 2013 Sales and Marketing BMS, Eliquis, NICE, Pfizer

In a move which will cheer Bristol-Myers Squibb and Pfizer, NICE has recommended oral blood-thinner Eliquis for use on the …

ABPI moves to improve compliance

February 28, 2013 Sales and Marketing ABPI, NHS, alltrials, goldaccre, whiehead

The ABPI has fired its latest salvo in the clinical trial transparency debate by announcing it will appoint a new …

UCB warns of data ‘voyeurism’

February 27, 2013 Research and Development, Sales and Marketing EFPIA, UCB, VBP, transparancy

UCB chief executive Roch Doliveux has attacked the idea of making all clinical trial data publicly available, saying it could …

Roche increases data access

February 27, 2013 Research and Development, Sales and Marketing ABPI, BMJ, Goldacre, Roche

Roche has launched a new process designed to enable greater access to its clinical trial data for researchers from outside …

The King’s Fund’s Anna Dixon joins Department of Health

February 27, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dixon, NHS, king's fund

Director of Policy at The King’s Fund Dr Anna Dixon will be joining the Department of Health in early May …

Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate

February 27, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead

In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …

Merck suffers brain cancer reverse

February 26, 2013 Sales and Marketing Merck, cilengitide

Merck’s oncology programme has suffered a setback as a Phase III trial of its investigational integrin inhibitor cilengitide failed in …

Elan sceptical of Royalty

February 26, 2013 Sales and Marketing Elan, FDA, Tysabri, royalty pharma

Elan Corporation has poured tepid water on private equity firm Royalty Pharma’s putative offer this week for the Irish biotech …

Pharmalink Consulting appoints five consultants

February 25, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmalink Consulting

Regulatory affairs firm Pharmalink Consulting has announced the appointment and promotion of five consultants at their offices in the UK, …

Abbott seeks leukemia test

February 25, 2013 Sales and Marketing AbbVie, Abbott, Janssen

Abbott is to team up with Janssen Biotech and biopharma firm Pharmacyclics to seek a diagnostic test for leukemia patients. …

Ariad expands in Europe

February 22, 2013 Sales and Marketing Ariad, leukaemia, leukemia

The new European boss of Ariad Pharmaceuticals has sketched out the US firm’s plans for its next-generation leukaemia drug, which …
The Gateway to Local Adoption Series

Latest content